IP Library Granted Patent US 7,413,572
Granted Patent B2
US 7,413,572 · App. 10/868,134 · Granted Aug 19, 2008

Adaptive control of optical pulses for laser medicine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,413,572
App. No.
10/868,134
Granted
Aug 19, 2008
Kind
B2
Abstract

Tissue is treated by irradiating it with a sequence of optical pulses that are directed in sequence to various sites on the tissue. During the irradiation sequence, one or more tissue properties are measured at a site(s) that has already been irradiated. These measurements are used to adjust the parameters of subsequent optical pulses in the sequence.

Claims (106)

1. A method for adaptive control of optical pulses used to irradiate tissue, comprising:

irradiating tissue with a sequence of optical pulses, the optical pulses directed in sequence to sites on the tissue;

during the irradiation sequence, making a measurement of a property of the tissue at a site already irradiated by one or more of the optical pulses; and

based on said measurement, adjusting a parameter of a subsequent optical pulse in the sequence according to an artificial intelligence algorithm.

2. The method of claim 1 wherein the step of adjusting the parameter comprises:

comparing the measurement with a predetermined value of the property; and

based on said comparison, adjusting the parameter of the subsequent optical pulse.

3. The method of claim 2 wherein the predetermined value is an end-point value of the property.

4. The method of claim 1 wherein the sequence of optical pulses is generated by laser scanning.

5. The method of claim 1 wherein the step of irradiating tissue with a sequence of optical pulses comprises:

irradiating one or more sites in the sequence of sites with multiple optical pulses.

6. The method of claim 1 wherein the step of irradiating tissue with a sequence of optical pulses comprises:

simultaneously irradiating one or more sites in the sequence of sites with multiple optical pulses.

7. The method of claim 1 wherein the parameter of the subsequent optical pulse includes a parameter selected from an energy of the optical pulse, a duration of the optical pulse, a temporal shape of the optical pulse, a spatial shape of the optical pulse, a propagation direction of the optical pulse relative to the tissue surface, a focusing characteristic of the optical pulse, a polarization of the optical pulse, and a wavelength spectrum of the optical pulse.

8. The method of claim 1 wherein the property of the tissue includes a property selected from mechanical density, electrical capacitance, dielectric constant, birefringence, opacity, optical reflectivity, absorption, extinction, elasticity, water fraction, melanin fraction, hemoglobin fraction, oxyhemoglobin fraction, and fraction of foreign matter.

9. The method of claim 1 wherein the property of the tissue includes a temperature of the tissue.

10. The method of claim 1 wherein the step of making a measurement of a property of the tissue at a site comprises:

making a measurement of a change in the property of the tissue at the site.

11. The method of claim 10 wherein the step of making a measurement of a change in the property of the tissue at the site comprises:

making a measurement of a change in the property of the tissue from before irradiation of the site by an optical pulse and after irradiation of the site by the optical pulse.

12. The method of claim 1 wherein:

the step of making a measurement of a property of the tissue at a site comprises:

making a measurement of the property at two or more sites already irradiated by optical pulses; and

taking a weighted average of said measurements; and

the step of adjusting a parameter of the subsequent optical pulse comprises:

adjusting the parameter based on the weighted average.

13. The method of claim 12 wherein:

the weighted average is an exponential weighted average.

14. The method of claim 12 wherein:

the weighted average is weighted according to time.

15. The method of claim 12 wherein:

the weighted average is weighted according to distance.

16. The method of claim 1 wherein the subsequent optical pulse is directed to the site already irradiated by one or more of the optical pulses.

17. The method of claim 1 wherein:

the step of making a measurement of a property of the tissue comprises making a measurement of two or more properties of the tissue; and

the step of adjusting the parameter comprises adjusting two or more parameters based on said measurements.

18. The method of claim 1 , wherein the parameter for the optical pulses is dithered.

19. The method of claim 1 further comprising:

determining a characteristic of the tissue based on the measurement, wherein the step of adjusting the parameter comprises adjusting the parameter in response to the determined characteristic.

20. The method of claim 1 further comprising:

determining a characteristic of the tissue based on the measurement; and

storing the determined characteristics.

21. The method of claim 20 further comprising:

irradiating tissue with a second sequence of optical pulses, the optical pulses directed in sequence to a second set of sites on the tissue;

accessing the stored characteristic of the tissue; and

adjusting a parameter of an optical pulse in the sequence in response to the accessed characteristic.

22. The method of claim 1 wherein said measurement and said irradiation by the subsequent optical pulse are separated by less than 1 second.

23. A method for adaptive control of optical pulses used to irradiate tissue, comprising:

irradiating tissue with a sequence of optical pulses, the optical pulses directed in sequence to sites on the tissue;

during the irradiation sequence, making measurements of a property of the tissue at two or more sites already irradiated by one or more of the optical pulses and taking a weighted average of the measurements; and

based on said measurements, adjusting a parameter of a subsequent optical pulse in the sequence based on the weighted average.

24. The method of claim 23 wherein the step of adjusting the parameter of a subsequent optical pulse in the sequence based on the weighted average comprises:

comparing the weighted average of the measurements of the property with a predetermined value of the property; and

based on said comparison, adjusting the parameter of the subsequent optical pulse.

25. The method of claim 24 wherein the predetermined value is an end-point value of the property.

26. The method of claim 23 wherein the sequence of optical pulses is generated by laser scanning.

27. The method of claim 23 wherein the step of irradiating tissue with a sequence of optical pulses comprises:

irradiating one or more sites in the sequence of sites with multiple optical pulses.

28. The method of claim 23 wherein the step of irradiating tissue with a sequence of optical pulses comprises:

simultaneously irradiating one or more sites in the sequence of sites with multiple optical pulses.

29. The method of claim 23 wherein the parameter of the subsequent optical pulse includes a parameter selected from an energy of the optical pulse, a duration of the optical pulse, a temporal shape of the optical pulse, a spatial shape of the optical pulse, a propagation direction of the optical pulse relative to the tissue surface, a focusing characteristic of the optical pulse, a polarization of the optical pulse, and a wavelength spectrum of the optical pulse.

30. The method of claim 23 wherein the property of the tissue includes a property selected from mechanical density, electrical capacitance, dielectric constant, birefringence, opacity, optical reflectivity, absorption, extinction, elasticity, water fraction, melanin fraction, hemoglobin fraction, oxyhemoglobin fraction, and fraction of foreign matter.

31. The method of claim 23 wherein the property of the tissue includes a temperature of the tissue.

32. The method of claim 23 wherein the subsequent optical pulse is directed to the site already irradiated by one or more of the optical pulses.

33. The method of claim 23 wherein the step of adjusting the parameter comprises:

adjusting the parameter according to an artificial intelligence algorithm.

34. The method of claim 23 wherein the step of adjusting the parameter comprises:

applying a predetermined rule to the measurement; and

adjusting the parameter according to the predetermined rule.

35. The method of claim 23 wherein:

the step of making a measurement of a property of the tissue comprises measuring two or more properties of the tissue; and

the step of adjusting the parameter comprises adjusting two or more parameters.

36. The method of claim 23 wherein the step of adjusting the parameter comprises:

adjusting the parameter according to a control algorithm.

37. The method of claim 36 wherein the step of adjusting the control algorithm includes a constraint on the adjusted parameter.

38. The method of claim 36 wherein the control algorithm dithers the parameter for the optical pulses.

39. The method of claim 23 wherein the step of adjusting the parameter comprises:

adjusting the parameter according to an algorithm selected from a moving simplex algorithm, a neural net algorithm, and a fuzzy logic algorithm.

40. The method of claim 23 further comprising:

determining a characteristic of the tissue based on the weighted average; and

storing the determined characteristics.

41. The method of claim 40 further comprising:

irradiating tissue with a second sequence of optical pulses, the optical pulses directed in sequence to a second site on the tissue;

accessing the stored characteristic of the tissue; and

adjusting a parameter of an optical pulse in the sequence in response to the accessed characteristic.

42. A method for adaptive control of optical pulses used to irradiate tissue, comprising:

irradiating tissue with a sequence of optical pulses, the optical pulses directed in sequence to sites on the tissue;

during the irradiation sequence, making a measurement of a property of the tissue at a site already irradiated by one or more of the optical pulses; and

based on said measurement, adjusting a parameter of a subsequent optical pulse in the sequence according to an algorithm selected from a moving simplex algorithm, a neural net algorithm, and a fuzzy logic algorithm.

43. The method of claim 42 wherein the step of adjusting the parameter comprises:

comparing a value of the measurement with a predetermined value of the property; and

based on said comparison, adjusting the parameter of the subsequent optical pulse according to said algorithm.

44. The method of claim 42 wherein the parameter of the subsequent optical pulse includes a parameter selected from an energy of the optical pulse, a duration of the optical pulse, a temporal shape of the optical pulse, a spatial shape of the optical pulse, a propagation direction of the optical pulse relative to the tissue surface, a focusing characteristic of the optical pulse, a polarization of the optical pulse, and a wavelength spectrum of the optical pulse.

45. The method of claim 42 wherein the property of the tissue includes a property selected from mechanical density, electrical capacitance, dielectric constant, birefringence, opacity, optical reflectivity, absorption, extinction, elasticity, water fraction, melanin fraction, hemoglobin fraction, oxyhemoglobin fraction, and fraction of foreign matter.

46. The method of claim 42 wherein the property of the tissue includes a temperature of the tissue.

47. The method of claim 42 wherein the step of making a measurement of a property of the tissue at a site comprises:

making a measurement of a change in the property of the tissue at two or more sites.

48. The method of claim 42 wherein the subsequent optical pulse is directed to the site already irradiated by one or more of the optical pulses.

49. The method of claim 42 wherein:

the step of making measurements of measuring a property of the tissue comprises making measurements of two or more properties of the tissue; and

the step of adjusting the parameter comprises adjusting two or more parameters based on said measurements according to said algorithm.

50. The method of claim 42 further comprising:

determining a characteristic of the tissue based on the measurement, wherein the step of adjusting the parameter comprises adjusting the parameter in response to the determined characteristic according to said algorithm.

51. The method of claim 42 further comprising:

determining a characteristic of the tissue based on the measurement; and

storing the determined characteristic.

Assignments (21)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 9, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 063942/0001 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
MERGER Recorded May 14, 2021
From: RELIANT TECHNOLOGIES, LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056244/0936 →
MERGER Recorded May 12, 2021
From: RELIANT TECHNOLOGIES, INC.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 056218/0067 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: SILICON VALLEY BANK
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 032125/0810 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: RELIANT TECHNOLOGIES, LLC
Reel/Frame 032126/0708 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: RELIANT TECHNOLOGIES, LLC
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0527 →
SECURITY INTEREST - MEZZANINE LOAN Recorded Apr 18, 2013
From: RELIANT TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 030248/0256 →
SECURITY AGREEMENT Recorded Jun 16, 2009
From: RELIANT TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 022824/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2004
From: EIMERL, DAVID; DEBENEDICTIS, LEONARD C.
To: RELIANT TECHNOLOGIES, INC.
Reel/Frame 015482/0191 →